-- Robert Preidt
TUESDAY, July 16 (HealthDay News) -- Some strains of the new
H7N9 bird flu virus that appeared in China this year are resistant
to antiviral drugs, and tests can fail to identify that resistance,
which could help accelerate their spread, a new study finds.
"We'd better get some vaccine seed stocks up and ready. The antiviral option for controlling H7N9 isn't too good," said study corresponding author Robert Webster, of St. Jude Children's Research Hospital in Memphis, Tenn.
Researchers analyzed viruses taken from the first person known
to have H7N9 infection and found that 35 percent of them were
resistant to Tamiflu (oseltamivir) and Relenza (zanamivir), which
are antiviral drugs used to treat H7N9 infections.
However, lab testing of the viruses failed to detect the strains
that were resistant, so using lab tests to monitor the development
of resistance in H7N9 would be useless, according to the authors of
the study, published July 16 in the online journal
Resistant strains of H7N9 can flourish in patients treated with
oseltamivir or zanamivir, inadvertently leading to the spread of
resistant infections, explained Webster.
"If H7N9 does acquire human-to-human transmissibility, what do we have to treat it with until we have a vaccine? Oseltamivir. We would be in big trouble," he said in a journal news release.
H7N9 first appeared in China in early 2013, in some cases
infecting people who had been in contact with poultry or had been
in places where poultry are housed. The virus has since been
detected in poultry at live markets near where human infections
have been reported. As of July 12, the number of H7N9 infections
was 132 and the number of deaths 43.
The U.S. Centers for Disease Control and Infection has more
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.